This research, published in Blood Advances defines how tumor microenvironment
network of tumor-associated macrophages and the mantle cell lymphoma
contributes to disease progression and alternative macrophage polarization.
Please click the link above for more information
Dr. Alejandro Villagra has received a new NIH R01 grant entitled "Development of selective HDAC6 inhibitors to improve cancer immunotherapy”, with a total funding amount of $3,024,000 for five years. The objective of this grant is to develop and test novel epigenetic drugs with the capacity of...